...
首页> 外文期刊>The journals of gerontology.Series A. Biological sciences and medical sciences >Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women
【24h】

Associations of Hearing Loss and Menopausal Hormone Therapy With Change in Global Cognition and Incident Cognitive Impairment Among Postmenopausal Women

机译:听力损失和绝经激素治疗随后妇女全球认知及事件认知障碍变化的关联

获取原文
获取原文并翻译 | 示例
           

摘要

Background Hearing loss (HL) and menopausal hormone therapy (conjugated equine estrogens [CEE] and/or medroxyprogesterone acetate [MPA]) are separately associated with cognitive decline and increased risk of incident cognitive impairment. Joint effects of HL and HT could be associated with additive or synergistic decline in global cognition and risk of incident cognitive impairment among postmenopausal women.
机译:背景技术听力损失(HL)和更年期激素治疗(共轭标准雌激素[CEE]和/或MEDROXYPRAGENTONE乙酸盐[MPA])与认知下降和事件认知障碍的风险增加,分别与认知下降相关。 HL和HT的联合效应可能与全球认知的添加剂或协同下降相关,并在绝经后妇女之间的事故认知障碍风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号